# The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment

> **NCT06292546** · NA · COMPLETED · sponsor: **Zhongshan Hospital (Xiamen), Fudan University** · enrollment: 72 (actual)

## Conditions studied

- Gut Microbiota
- Metabolic Disturbance
- Helicobacter Pylori Eradication

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Amoxicillin
- **DRUG:** Bacillus subtilis enteric-coated capsules

## Key facts

- **NCT ID:** NCT06292546
- **Lead sponsor:** Zhongshan Hospital (Xiamen), Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-31
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-02-28
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06292546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06292546, "The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT06292546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*